Commodore-Mensah Yvonne, Delva Sabianca, Ogungbe Oluwabunmi, Smulcer Lauren A, Rives Sally, Dennison Himmelfarb Cheryl R, Kim Miyong T, Bone Lee, Levine David, Hill Martha N
Johns Hopkins School of Nursing, Baltimore, MD, USA.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Patient Prefer Adherence. 2023 Sep 28;17:2401-2420. doi: 10.2147/PPA.S412198. eCollection 2023.
Poor medication adherence hampers hypertension control and increases the risk of adverse health outcomes. Medication adherence can be measured with direct and indirect methods. The Hill-Bone Compliance to High Blood Pressure Therapy (HBCHBPT) Scale, one of the most popular adherence measures, indirectly assesses adherence to hypertension therapy in three behavioral domains: appointment keeping, diet and medication adherence.
To synthesize evidence on the use of the HBCHBPT Scale, including psychometric properties, utility in diverse patient populations, and directions for future clinical use and research.
We searched electronic databases, specifically CINAHL, PubMed, PsychInfo, Embase, and Web of Science. We included original studies that used the HBCHBPT Scale or its subscales to measure a health outcome, or methodological studies involving translations and validations of the scale. We extracted and synthesized data following the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines.
Fifty studies were included in this review, 44 on hypertension, two on diabetes, and others on other chronic conditions. The scale was successfully translated into numerous languages and used in descriptive and intervention studies. The scale demonstrated sound psychometric properties (Cronbach's α coefficient 0.75) and sensitivity to capture intervention effects when used to evaluate the effectiveness of high blood pressure adherence interventions. The medication-taking subscale of HBCHBPT performs best and is widely used in diverse contexts to assess medication adherence for chronic conditions.
The HBCHBPT Scale has high versatility globally and has been used in various settings by various healthcare worker cadres and researchers. The scale has several strengths, including high adherence phenotyping capabilities, contributing to the paradigm shift toward personalized health care.
用药依从性差会妨碍高血压的控制，并增加不良健康结局的风险。用药依从性可以通过直接和间接方法进行测量。希尔-博恩高血压治疗依从性量表（HBCHBPT量表）是最常用的依从性测量工具之一，它在三个行为领域间接评估高血压治疗的依从性：就诊依从性、饮食依从性和用药依从性。
综合关于HBCHBPT量表使用的证据，包括心理测量特性、在不同患者群体中的效用以及未来临床应用和研究的方向。
我们检索了电子数据库，特别是护理学与健康领域数据库（CINAHL）、医学期刊数据库（PubMed）、心理学文摘数据库（PsychInfo）、荷兰医学文摘数据库（Embase）和科学引文索引数据库（Web of Science）。我们纳入了使用HBCHBPT量表或其子量表测量健康结局的原始研究，或涉及该量表翻译和验证方面的方法学研究。我们按照系统评价和Meta分析的首选报告项目（PRISMA）指南提取和综合数据。
本综述纳入了50项研究，其中44项关于高血压，2项关于糖尿病，其他研究涉及其他慢性病。该量表已成功翻译成多种语言，并用于描述性研究和干预性研究。该量表显示出良好的心理测量特性（克朗巴哈α系数为0.75），在用于评估高血压依从性干预措施的有效性时，对捕捉干预效果具有敏感性。HBCHBPT量表的用药子量表表现最佳，在各种情况下被广泛用于评估慢性病的用药依从性。
HBCHBPT量表在全球具有很高的通用性，已被不同医疗工作者群体和研究人员在各种环境中使用。该量表有几个优点，包括高依从性表型分析能力，有助于向个性化医疗的范式转变。
